Changes

no edit summary
Line 747: Line 747:  
|
 
|
 
|
 
|
|
+
|Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1
 
|Tracy Tucker, PhD, FCCMG
 
|Tracy Tucker, PhD, FCCMG
 
|
 
|
Line 763: Line 763:  
|
 
|
 
|
 
|
|
+
|Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged
 
|Tracy Tucker, PhD, FCCMG
 
|Tracy Tucker, PhD, FCCMG
 
|
 
|
Line 779: Line 779:  
|
 
|
 
|
 
|
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]]
 
|[[HAEM5:Mixed-phenotype acute leukaemia, B/myeloid|Mixed-phenotype acute leukaemia, B/myeloid]]
Line 795: Line 795:  
|
 
|
 
|
 
|
|
+
|Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified
 
|Priyatharsini Nirmalanantham, MD and  Shashi Shetty, PhD
 
|Priyatharsini Nirmalanantham, MD and  Shashi Shetty, PhD
 
|
 
|
Line 811: Line 811:  
|
 
|
 
|
 
|
|
+
|Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified
 
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
 
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine
 
|
 
|
Line 827: Line 827:  
|
 
|
 
|
 
|
|
+
|Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types
 
|Elicia Goodale, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina
 
|Elicia Goodale, MD, Medical University of South Carolina  Daynna Wolff, PhD, Medical University of South Carolina
 
|
 
|
Line 843: Line 843:  
|
 
|
 
|
 
|
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]]
 
|[[HAEM5:Acute undifferentiated leukaemia|Acute undifferentiated leukaemia]]
Line 859: Line 859:  
|
 
|
 
|
 
|
|
+
|Acute Undifferentiated Leukemia
 
|Amelia Nakanishi, MD and Shashi Shetty, PhD
 
|Amelia Nakanishi, MD and Shashi Shetty, PhD
 
|
 
|